Chi Sheng Pharma & Biotech Co., Ltd
4111
Rank in Stocks
#22596
Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged... Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, and local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.
Share Price
$0.86575863
Last synced: 2026-11-10
Market Cap
$51.80M
Change (1 day)
-0.18%
Change (1 year)
-10.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Chi Sheng Pharma & Biotech Co., Ltd (4111)
Category
Healthcare
Operating Margin for Chi Sheng Pharma & Biotech Co., Ltd (4111)
Operating Margin as of November 2026 TTM: 14.36%
According to Chi Sheng Pharma & Biotech Co., Ltd's latest financial reports, its current operating margin (TTM) is 14.36%. At the end of 2025 the company had an operating margin of 14.48%.
Operating Margin history for Chi Sheng Pharma & Biotech Co., Ltd from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.36% | -0.83% |
| 2025 | 14.48% | 70.55% |
| 2024 | 8.49% | 47.14% |
| 2023 | 5.77% | -59.73% |
| 2022 | 14.33% | 10.23% |
| 2021 | 13.00% | 56.06% |
| 2020 | 8.33% | -12.59% |
| 2019 | 9.53% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -98.02% |
US
|
|
| 12.36% | -99.14% |
FR
|
|
| 9.83% | -99.32% |
US
|
|
| 31.11% | -97.83% |
JP
|
|
| 9.87% | -99.31% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Chi Sheng Pharma & Biotech Co., Ltd's operating margin
What is Chi Sheng Pharma & Biotech Co., Ltd's operating margin?
Chi Sheng Pharma & Biotech Co., Ltd's operating margin is 14.36%, as of Nov 2026.
What was Chi Sheng Pharma & Biotech Co., Ltd's operating margin in 2025?
In 2025, Chi Sheng Pharma & Biotech Co., Ltd's operating margin was 14.48%, compared with 8.49% in 2024.
How has Chi Sheng Pharma & Biotech Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, Chi Sheng Pharma & Biotech Co., Ltd's operating margin was highest in 2025 (14.48%) and lowest in 2023 (5.77%).
How does Chi Sheng Pharma & Biotech Co., Ltd's operating margin compare with similar companies?
Chi Sheng Pharma & Biotech Co., Ltd's operating margin (14.36%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.